She received advisory/consulting fees and/or other support from: Novo Nordisk, Eli Lilly and Company, Sanofi, AstraZeneca, Boehringer Ingelheim, Janssen, Intercept, Intarcia, Target Pharma, Merck, Pfizer, Novartis, GI Dynamics, Mylan, Mannkind, Valeritas, Zealand Pharma, Shionogi, Carmot and Bayer
We recommend a proactive monitoring schedule: Initial Monitoring: Test your thyroid levels (TSH and Free T4) before starting tirzepatide to establish a baseline
Potential Cardiovascular Benefits: Some preliminary research suggests that Tirzepatide may have positive effects on cardiovascular health
In addition to the results from SURPASS 4, which was designed to provide preliminary evidence for the cardiovascular safety of tirzepatide, a separate analysis pooling all the clinical trials with tirzepatide was used to generate a pre-specified estimate of cardiovascular events [20] (Table 1)
In research settings, it is used to study incretin receptor crosstalk, metabolic signaling, and downstream glucose-response pathways [1]